Simplex Trading, LLC Cytom X Therapeutics, Inc. Transaction History

Simplex Trading, LLC

$156 Billion
Q1 2025

A detailed history of Simplex Trading, LLC transactions in Cytom X Therapeutics, Inc. stock. As of the latest transaction made, Simplex Trading, LLC holds 33,853 shares of CTMX stock, worth $78,200. This represents 0.0% of its overall portfolio holdings.

Number of Shares

33,853

Previous 507 6577.12%

Holding current value

$78,200

Previous $0 Infinity%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$0.58 - $1.14 $19,340 - $38,014	33,346 Added 6577.12%	33,853 $21,000
Q4 2024 Feb 11, 2025	BUY	$0.86 - $1.29 $436 - $654	507 New	507 $0
Q2 2024 Jul 25, 2024	SELL	$1.21 - $5.13 $2,629 - $11,147	-2,173 Reduced 35.83%	3,891 $4,000
Q1 2024 Apr 25, 2024	BUY	$1.41 - $2.74 $8,550 - $16,615	6,064 New	6,064 $13,000
Q2 2023 Aug 04, 2023	BUY	$1.41 - $1.92 $999 - $1,361	709 New	709 $1,000
Q1 2022 May 02, 2022	SELL	$2.67 - $4.68 $16,431 - $28,800	-6,154 Reduced 99.77%	14 $0
Q2 2021 Aug 12, 2021	BUY	$6.33 - $9.91 $39,043 - $61,124	6,168 New	6,168 $39,000
Q3 2020 Oct 14, 2020	SELL	$6.55 - $8.83 $1,689 - $2,278	-258 Closed	0 $0
Q2 2020 Jul 13, 2020	SELL	$7.4 - $14.64 $791 - $1,566	-107 Reduced 29.32%	258 $2,000
Q1 2020 Apr 29, 2020	SELL	$3.61 - $8.6 $58,225 - $138,709	-16,129 Reduced 97.79%	365 $2,000
Q4 2019 Feb 05, 2020	BUY	$5.17 - $8.91 $85,273 - $146,961	16,494 New	16,494 $137,000
Q2 2019 Jul 26, 2019	SELL	$9.35 - $11.41 $1,346 - $1,643	-144 Closed	0 $0
Q1 2019 Apr 18, 2019	BUY	$9.5 - $19.16 $1,368 - $2,759	144 New	144 $0
Q2 2018 Jul 30, 2018	SELL	$21.38 - $29.68 $1,902 - $2,641	-89 Closed	0 $0
Q1 2018 Apr 26, 2018	BUY	$21.76 - $34.22 $1,936 - $3,045	89 New	89 $2,000
Q4 2017 Jan 10, 2018	SELL	$19.0 - $23.09 $5,510 - $6,696	-290 Closed	0 $0
Q3 2017 Oct 25, 2017	BUY	$13.53 - $18.17 $3,923 - $5,269	290	290 $5,000

Others Institutions Holding CTMX

# of Institutions

Shares Held

44.9M

Call Options Held

8.9K

Put Options Held

47.9K

View Full List

About CytomX Therapeutics, Inc.

Ticker CTMX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,950,200
Market Cap $152M
Description
CytomX Therapeutics, Inc. operates as an oncology-focused biopharmaceutical company in the United States. The company develops antibody therapeutics based on its Probody technology platform for the treatment of cancer. The company's product candidates include CX-2009, an antibody drug conjugates (ADC) against CD166, which is in Phase II clinical...

More about CTMX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Simplex Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Simplex Trading, LLC with notifications on news.

Account

Simplex Trading, LLC Cytom X Therapeutics, Inc. Transaction History